Editorial Comment to Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
Uchida
Toyoaki
T
D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods*; D011183:Postoperative Complications / Q000503:physiopathology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D016019:Survival Analysis; D013997:Time Factors; D020728:Transurethral Resection of Prostate / Q000379:methods*; D016896:Treatment Outcome; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000009:adverse effects / Q000379:methods*; D014525:Urethral Stricture / Q000209:etiology / Q000503:physiopathology; D014555:Urination Disorders / Q000209:etiology / Q000503:physiopathology